ProShare Advisors
STML

ProShare Advisors’s Stemline Therapeutics, Inc. STML Stock Holding History

ProShare Advisors’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,778
Closed -$262K – 2066
2013
Q3 		$262K Buy
+5,778
New +$262K 0.01% 1995